Retinopathy of Prematurity Both Eyes

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Retinopathy of Prematurity Both Eyes trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06520410

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's…

Taiwan60 participantsStarted 2024-03-05

Treatment: Pars plana vitrectomy with a 18 mm short vitrector

All recent trials (3 shown)

UnknownPhase 3

NCT05033106

Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity

Retinopathy of prematurity (ROP) with inadequate growth and development of retinal blood vessels in premature infants is one of the foremost reasons for childho…

Egypt36 participantsStarted 2020-09-01

Treatment: Bevacizumab, Ranibizumab

CompletedPhase 4

NCT03148132

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

The Retinopathy of Prematurity (ROP) is one of the leading causes of blindness on the pediatric age worldwide. This pathology is characterized for arrest of the…

Mexico16 participantsStarted 2017-05-23

Treatment: Bevacizumab Injection, Ranibizumab Ophthalmic